---
title: "Severe illness after vaccination"
image: "https:\/\/i.ytimg.com\/vi\/vOyB2PyRf-k\/hqdefault.jpg"
vid_id: "vOyB2PyRf-k"
categories: "Education"
tags: ["physiology","nursing","NCLEX"]
date: "2021-11-02T13:58:17+03:00"
vid_date: "2021-10-31T20:41:27Z"
duration: "PT29M45S"
viewcount: "647933"
likeCount: "17017"
dislikeCount: "1063"
channel: "Dr. John Campbell"
---
{% raw %}Hospitalisation among vaccine breakthrough COVID-19 infections<br /><br /><a rel="nofollow" target="blank" href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00558-2/fulltext">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00558-2/fulltext</a><br /><br />Robust vaccine efficacies at preventing severe symptomatic disease<br /><br />Breakthrough SARS-CoV-2 infections in fully vaccinated<br /><br /><a rel="nofollow" target="blank" href="https://covid.joinzoe.com/post/worryingly-close-to-100-000-new-cases-a-day">https://covid.joinzoe.com/post/worryingly-close-to-100-000-new-cases-a-day</a><br /><br />Impact of vaccination on admission to hospital<br /><br />Patients with confirmed SARS-CoV-2 infection<br /><br />Yale New Haven Health System, Connecticut<br /><br />Between March 23 and July 1, 2021<br /><br />Patients were considered fully vaccinated 14 days after second dose<br /><br />969 patients were admitted PCR positive<br /><br />172 (18%) of 969 patients had received at least one vaccine dose<br /><br />103 had received a partial vaccine course<br /><br />15 had received a complete course<br /><br />54 were fully vaccinated<br /><br />Among the 54<br /><br />25 (46%) patients were asymptomatic<br /><br />4 (7%) had mild disease<br /><br />11 (20%) had moderate disease<br /><br />14 (26%) had severe or critical illness<br /><br />4 (7%) required ICU<br /><br />1 required ventilation<br /><br />3 died<br /><br />Among those with severe or critical illness<br /><br />Median age 80·5 years<br /><br />Pre-existing comorbidities in the 14 patients with severe or critical illness<br /><br />Body–mass index more than 25 kg/m² (n=9)<br /><br />Cardiovascular disease (n=12)<br /><br />Lung disease (n=7)<br /><br />Malignancy (n=4)<br /><br />Type 2 diabetes (n=7)<br /><br />Immunosuppressive agent (n=4)<br /><br />Difference between vaccines<br /><br />13 of 14 patients had received BNT162b2, Pfizer<br /><br />1 of the 14 had received mRNA-1273, Moderna<br /><br />0 of the 14 had received Ad.26. COV2.S, J and J<br /><br />May 17, 2021, vaccine doses in Connecticut<br /><br />Pfizer, 1, 358, 175<br /><br />Moderna, 1, 044, 420<br /><br />J and J, 267, 000{% endraw %}
